Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting polo-like kinase: learning too little too late?

× No keyword cloud information.

4 in total

1. Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.

Authors: Jie Lu; John S Kovach; Francis Johnson; Jeffrey Chiang; Richard Hodes; Russell Lonser; Zhengping Zhuang
Journal: Proc Natl Acad Sci U S A Date: 2009-06-29 Impact factor: 11.205

2. Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.

Authors: Kaiji Hu; Cathy Lee; Dexin Qiu; Abbas Fotovati; Alastair Davies; Samah Abu-Ali; Daniel Wai; Elizabeth R Lawlor; Timothy J Triche; Catherine J Pallen; Sandra E Dunn
Journal: Mol Cancer Ther Date: 2009-11-03 Impact factor: 6.261

3. Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells.

Authors: Monika Raab; Sven Kappel; Andrea Krämer; Mourad Sanhaji; Yves Matthess; Elisabeth Kurunci-Csacsko; Julia Calzada-Wack; Birgit Rathkolb; Jan Rozman; Thure Adler; Dirk H Busch; Irene Esposito; Helmut Fuchs; Valérie Gailus-Durner; Martin Klingenspor; Eckhard Wolf; Nicole Sänger; Florian Prinz; Martin Hrabě de Angelis; Jost Seibler; Juping Yuan; Martin Bergmann; Rainald Knecht; Bertolt Kreft; Klaus Strebhardt
Journal: Nat Commun Date: 2011-07-19 Impact factor: 14.919

4. Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma.

Authors: Yonghuan Mao; Ling Xi; Quan Li; Sheng Wang; Zeling Cai; Xinhua Zhang; Chunzhao Yu
Journal: Transl Oncol Date: 2018-05-10 Impact factor: 4.243

4 in total